Compare $OTLC vs $XCUR | Chartloom

Compare

$OTLC vs $XCUR

Oncotelic Therapeutics Inc · Exicure Inc

OTLC

Oncotelic Therapeutics Inc

XCUR

Exicure Inc

Compare $OTLC vs $XCUR

Comparing Oncotelic Therapeutics Inc and Exicure Inc

OTLCOncotelic Therapeutics Inc

XCURExicure Inc

OTLCOncotelic Therapeutics Inc

Market cap

$9M

P/E (TTM)

0.04x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.0%

52W performance

-76.9%

FCF yield

-16.5%

XCURExicure Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-80.3%

FCF yield

-105.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OTLC

XCUR

Detailed metrics comparison

OTLC

Oncotelic Therapeutics Inc

XCUR

Exicure Inc

Market Cap

OTLC$9M

XCUR$7M

Enterprise Value

OTLC$23M

XCUR$5M

Price

OTLC$0.02

XCUR$1.05

P/E Ratio

OTLC0.04x

XCURN/A

P/S Ratio

OTLC36.91x

XCUR14.24x

EV/Sales

OTLC91.75x

XCUR10.81x

EV/EBITDA

OTLC0.00x

XCUR0.90x

P/B Ratio

OTLC0.04x

XCUR7.29x

P/FCF Ratio

OTLCN/A

XCURN/A

EV/FCF

OTLC-15.05x

XCUR-0.71x

PEG Ratio

OTLCN/A

XCURN/A

Forward P/E (NTM)

OTLCN/A

XCURN/A

Forward P/S (NTM)

OTLCN/A

XCURN/A

Revenue (TTM)

OTLC$250K

XCUR$0

Revenue Growth (YoY)

OTLCN/A

XCURN/A

Forward Rev Growth

OTLC0.0%

XCUR0.0%

Gross Margin (TTM)

OTLC83.1%

XCUR0.0%

Operating Margin (TTM)

OTLC0.0%

XCUR0.0%

EBITDA Margin (TTM)

OTLC-1545.3%

XCUR0.0%

Net Margin (TTM)

OTLC99875.6%

XCUR0.0%

FCF Margin (TTM)

OTLC-609.8%

XCURN/A

Net Income (TTM)

OTLC$250M

XCUR$-8M

FCF (TTM)

OTLC$-2M

XCUR$-7M

EPS (TTM)

OTLC$0.53

XCUR-$1.30

ROE (TTM)

OTLC139.7%

XCUR-23791.0%

ROA (TTM)

OTLC91.8%

XCUR-6198.0%

ROIC (TTM)

OTLC129.6%

XCUR-23791.0%

Cash

OTLC$186K

XCUR$2M

Debt

OTLC$14M

XCUR$0

Net Cash/Debt

OTLC$-14M

XCUR$2M

Current Ratio (TTM)

OTLC0.08x

XCUR0.56x

Quick Ratio (TTM)

OTLC0.01x

XCUR0.43x

Debt/Equity (TTM)

OTLC0.05x

XCUR0.00x

Debt/Assets (TTM)

OTLC0.0%

XCUR0.0%

Interest Coverage (TTM)

OTLCN/A

XCURN/A

Net Debt/EBITDA (TTM)

OTLC0.00x

XCUR0.00x

Beta

OTLC-0.07

XCUR3.86

52W Performance

OTLC-76.9%

XCUR-80.3%

YTD Performance

OTLC-74.0%

XCUR-81.2%

% from 52W High

OTLC-81.1%

XCUR-88.9%

% from 52W Low

OTLC4.0%

XCUR12.2%

Asset Turnover (TTM)

OTLC0.00x

XCUR0.05x

FCF Yield (TTM)

OTLC-16.5%

XCUR-105.0%

Earnings Yield (TTM)

OTLC2706.0%

XCUR-123.9%

Dividend Yield (TTM)

OTLCN/A

XCURN/A

Rule of 40

OTLC-609.8

XCUR0.0

EV/GP/RG

OTLCN/A

XCURN/A

Ticker research

View OTLC research View XCUR research

Metric	OTLC Oncotelic Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$9M	$7M
Enterprise Value	$23M	$5M
Price	$0.02	$1.05
P/E Ratio	0.04x	N/A
P/S Ratio	36.91x	14.24x
EV/Sales	91.75x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	0.04x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.05x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$250K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	83.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1545.3%	0.0%
Net Margin (TTM)	99875.6%	0.0%
FCF Margin (TTM)	-609.8%	N/A
Net Income (TTM)	$250M	$-8M
FCF (TTM)	$-2M	$-7M
EPS (TTM)	$0.53	-$1.30
ROE (TTM)	139.7%	-23791.0%
ROA (TTM)	91.8%	-6198.0%
ROIC (TTM)	129.6%	-23791.0%
Financial Health
Cash	$186K	$2M
Debt	$14M	$0
Net Cash/Debt	$-14M	$2M
Current Ratio (TTM)	0.08x	0.56x
Quick Ratio (TTM)	0.01x	0.43x
Debt/Equity (TTM)	0.05x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	3.86
52W Performance	-76.9%	-80.3%
YTD Performance	-74.0%	-81.2%
% from 52W High	-81.1%	-88.9%
% from 52W Low	4.0%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-16.5%	-105.0%
Earnings Yield (TTM)	2706.0%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-609.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OTLC research	View XCUR research

Valuation

P/E Ratio

OTLC

0.04x

P/S Ratio

XCUR

14.24x

OTLC

36.91x

EV/FCF

OTLC

-15.05x

XCUR

-0.71x

Growth & revenue

Forward Revenue Growth

OTLC

0.0%

XCUR

0.0%

Profitability & performance

Gross Margin

OTLC

83.1%

XCUR

0.0%

ROE

OTLC

139.7%

XCUR

-23791.0%

FCF Yield %

OTLC

-16.5%

XCUR

-105.0%

52-Week Performance

OTLC

-76.9%

XCUR

-80.3%

Detailed metrics comparison

OTLC

Oncotelic Therapeutics Inc

XCUR

Exicure Inc

Market Cap

OTLC$9M

XCUR$7M

Enterprise Value

OTLC$23M

XCUR$5M

Price

OTLC$0.02

XCUR$1.05

P/E Ratio

OTLC0.04x

XCURN/A

P/S Ratio

OTLC36.91x

XCUR14.24x

EV/Sales

OTLC91.75x

XCUR10.81x

EV/EBITDA

OTLC0.00x

XCUR0.90x

P/B Ratio

OTLC0.04x

XCUR7.29x

P/FCF Ratio

OTLCN/A

XCURN/A

EV/FCF

OTLC-15.05x

XCUR-0.71x

PEG Ratio

OTLCN/A

XCURN/A

Forward P/E (NTM)

OTLCN/A

XCURN/A

Forward P/S (NTM)

OTLCN/A

XCURN/A

Revenue (TTM)

OTLC$250K

XCUR$0

Revenue Growth (YoY)

OTLCN/A

XCURN/A

Forward Rev Growth

OTLC0.0%

XCUR0.0%

Gross Margin (TTM)

OTLC83.1%

XCUR0.0%

Operating Margin (TTM)

OTLC0.0%

XCUR0.0%

EBITDA Margin (TTM)

OTLC-1545.3%

XCUR0.0%

Net Margin (TTM)

OTLC99875.6%

XCUR0.0%

FCF Margin (TTM)

OTLC-609.8%

XCURN/A

Net Income (TTM)

OTLC$250M

XCUR$-8M

FCF (TTM)

OTLC$-2M

XCUR$-7M

EPS (TTM)

OTLC$0.53

XCUR-$1.30

ROE (TTM)

OTLC139.7%

XCUR-23791.0%

ROA (TTM)

OTLC91.8%

XCUR-6198.0%

ROIC (TTM)

OTLC129.6%

XCUR-23791.0%

Cash

OTLC$186K

XCUR$2M

Debt

OTLC$14M

XCUR$0

Net Cash/Debt

OTLC$-14M

XCUR$2M

Current Ratio (TTM)

OTLC0.08x

XCUR0.56x

Quick Ratio (TTM)

OTLC0.01x

XCUR0.43x

Debt/Equity (TTM)

OTLC0.05x

XCUR0.00x

Debt/Assets (TTM)

OTLC0.0%

XCUR0.0%

Interest Coverage (TTM)

OTLCN/A

XCURN/A

Net Debt/EBITDA (TTM)

OTLC0.00x

XCUR0.00x

Beta

OTLC-0.07

XCUR3.86

52W Performance

OTLC-76.9%

XCUR-80.3%

YTD Performance

OTLC-74.0%

XCUR-81.2%

% from 52W High

OTLC-81.1%

XCUR-88.9%

% from 52W Low

OTLC4.0%

XCUR12.2%

Asset Turnover (TTM)

OTLC0.00x

XCUR0.05x

FCF Yield (TTM)

OTLC-16.5%

XCUR-105.0%

Earnings Yield (TTM)

OTLC2706.0%

XCUR-123.9%

Dividend Yield (TTM)

OTLCN/A

XCURN/A

Rule of 40

OTLC-609.8

XCUR0.0

EV/GP/RG

OTLCN/A

XCURN/A

Ticker research

View OTLC research View XCUR research

Metric	OTLC Oncotelic Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$9M	$7M
Enterprise Value	$23M	$5M
Price	$0.02	$1.05
P/E Ratio	0.04x	N/A
P/S Ratio	36.91x	14.24x
EV/Sales	91.75x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	0.04x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.05x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$250K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	83.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1545.3%	0.0%
Net Margin (TTM)	99875.6%	0.0%
FCF Margin (TTM)	-609.8%	N/A
Net Income (TTM)	$250M	$-8M
FCF (TTM)	$-2M	$-7M
EPS (TTM)	$0.53	-$1.30
ROE (TTM)	139.7%	-23791.0%
ROA (TTM)	91.8%	-6198.0%
ROIC (TTM)	129.6%	-23791.0%
Financial Health
Cash	$186K	$2M
Debt	$14M	$0
Net Cash/Debt	$-14M	$2M
Current Ratio (TTM)	0.08x	0.56x
Quick Ratio (TTM)	0.01x	0.43x
Debt/Equity (TTM)	0.05x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	3.86
52W Performance	-76.9%	-80.3%
YTD Performance	-74.0%	-81.2%
% from 52W High	-81.1%	-88.9%
% from 52W Low	4.0%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-16.5%	-105.0%
Earnings Yield (TTM)	2706.0%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-609.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OTLC research	View XCUR research